Retrospective analysis of a group of patients with advanced Non-Small-Cell lung cancer (NSCLC) treated with Gefitinib

被引：0
|
作者：
Bandera, M. [1 ]
Bascialla, L. [1 ]
Martinelli, B. [1 ]
Masera, G. L. Rodolfo [1 ]
Vallini, I. [1 ]
Zanlorenzi, L. [1 ]
Pinotti, G. [1 ]
机构：
[1] Osped Circolo & Fondazione Macchi, UO Oncol Med, Varese, Italy
来源：
ANNALS OF ONCOLOGY | 2005年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：25 / 25
页数：1
相关论文
共 50 条
  • [1] Gefitinib Monotherapy in Advanced non-small-cell Lung Cancer: A Retrospective Analysis
    Shrestha, S.
    Joshi, P.
    [J]. JOURNAL OF NEPAL MEDICAL ASSOCIATION, 2012, 52 (02) : 66 - 71
  • [2] Predictive factors associated with prolonged survival in patients with advanced non-small-cell lung cancer (NSCLC) treated with gefitinib
    Satouchi, M.
    Negoro, S.
    Funada, Y.
    Urata, Y.
    Shimada, T.
    Yoshimura, S.
    Kotani, Y.
    Sakuma, T.
    Watanabe, H.
    Adachi, S.
    Takada, Y.
    Yatabe, Y.
    Mitsudomi, T.
    [J]. BRITISH JOURNAL OF CANCER, 2007, 96 (08) : 1191 - 1196
  • [3] Predictive factors associated with prolonged survival in patients with advanced non-small-cell lung cancer (NSCLC) treated with gefitinib
    M Satouchi
    S Negoro
    Y Funada
    Y Urata
    T Shimada
    S Yoshimura
    Y Kotani
    T Sakuma
    H Watanabe
    S Adachi
    Y Takada
    Y Yatabe
    T Mitsudomi
    [J]. British Journal of Cancer, 2007, 96 : 1191 - 1196
  • [4] Gefitinib plus interleukin-2 in previously treated patients with advanced non-small-cell lung cancer (NSCLC)
    Longarini, Raffaella
    Buti, Sebastiano
    Bosio, Giancarlo
    Brighenti, Matteo
    Porzio, Rosa
    Negri, Federica
    Passalacqua, Rodolfo
    [J]. ANNALS OF ONCOLOGY, 2007, 18 : 30 - 30
  • [5] Gefitinib for Chinese patients with advanced non-small-cell lung cancer
    Xiaotong, Z
    Longyun, L
    Xinlin, MU
    [J]. LUNG CANCER, 2004, 45 : S79 - S79
  • [6] Predictive factors associated with gefitinib response in patients with advanced non-small-cell lung cancer (NSCLC)
    Chen, Lian
    Chen, Rui
    Zhu, Zhe
    Zhang, Yichen
    Wen, Zhengwei
    Li, Yun
    Li, Xiaoming
    Luo, Yuwen
    Ma, Liyu
    Lin, Shuguang
    Chen, Xin
    [J]. CHINESE JOURNAL OF CANCER RESEARCH, 2014, 26 (04) : 466 - 470
  • [7] Efficacy and tolerability of gefitinib in pretreated elderly patients with advanced non-small-cell lung cancer (NSCLC)
    Cappuzzo, F
    Bartolini, S
    Ceresoli, GL
    Tamberi, S
    Spreafico, A
    Lombardo, L
    Gregorc, V
    Toschi, L
    Calandri, C
    Villa, E
    Crinò, L
    [J]. BRITISH JOURNAL OF CANCER, 2004, 90 (01) : 82 - 86
  • [8] PREDICTIVE FACTORS ASSOCIATED WITH GEFITINIB RESPONSE IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC)
    Xu, F.
    Zhou, T.
    Duan, J.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 47 - 47
  • [9] Efficacy and tolerability of gefitinib in pretreated elderly patients with advanced non-small-cell lung cancer (NSCLC)
    F Cappuzzo
    S Bartolini
    G L Ceresoli
    S Tamberi
    A Spreafico
    L Lombardo
    V Gregorc
    L Toschi
    C Calandri
    E Villa
    L Crinò
    [J]. British Journal of Cancer, 2004, 90 : 82 - 86
  • [10] Predictive factors associated with gefitinib response in patients with advanced non-small-cell lung cancer(NSCLC)
    Lian Chen
    Rui Chen
    Zhe Zhu
    Yichen Zhang
    Zhengwei Wen
    Yun Li
    Xiaoming Li
    Yuwen Luo
    Liyu Ma
    Shuguang Lin
    Xin Chen
    [J]. Chinese Journal of Cancer Research, 2014, 26 (04) : 466 - 470
12345